📑(NU/1257) Provision of Clinical Trial Research Services for Vision-DMD 2b and Extension Study
Procurement process summary
This process is to purchase (NU/1257) Provision of Clinical Trial Research Services for Vision-DMD 2b and Extension Study.
This contract was awarded by 🇬🇧 Newcastle University for an amount of EUR 371,964 to 1 supplier. It was published on 2017-02-18 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇬🇧 Newcastle University Buying unitnot reported Publication date2017-02-18 Contest statusnot reported DescriptionVision-DMD aims to advance clinical development of the orphan drug VBP15 (Vamorolone) as a new therapy to revolutionise care for all patients with Duchenne Muscular Dystrophy (DMD). The scope of this contract relates specifically to the Phase 2b randomized, double-blind, parallel placebo and active-controlled study to assess the efficacy and safety of Vamorolone in ambulatory boys with Duchenne Muscular Dystrophy and the extension study that will follow this. A registered Clinical Trial Unit (CTU) or Contracted Research Organisation (CRO) is required to set up and manage the clinical trial at sites in UK/Sweden/Australia/Israel. The CTU/CRO will be carrying out delegated duties on behalf of the sponsor, ReveraGen, but will be receiving payments for these duties from the Vision-DMD Horizon 2020 grant, coordinated by Newcastle University.Awards
This award was granted to Novotech by Newcastle University for an amount of EUR 371,964. The procurement process was conducted through open for the category of services. The award was granted on 2017-08-23. This is award number 2.
This contract has multiple awards. This is award number 2. View other awards for this contract
| Supplier | Amount | Award date | Award number |
|---|---|---|---|
| 🇦🇺 Novotech | EUR 371,964 | 2017-08-23 | 2 |
Market context and opportunities
The execution of this contract allows the entity Newcastle University to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUK_ocds-70d2nz-059f7eb3-6fd2-41d6-a395-99e12a712dc7-award-2Publication date2017-02-18Contract datenot reportedAward date2017-08-23CategoriesservicesPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
